长风药业（股票代码：02652）于2026年5月29日发布公告，披露其于当日于香港联交所场内回购普通H股4.55万股，占前一交易日已发行股本的0.0151%。本次回购每股价格介乎港币19.81元至20.88元，总金额约94.04万港元。
公告显示，本次回购前，公司已发行股份总数为301,053,086股，库藏股数量为1,170,500股；回购后，已发行股份总数变为301,007,586股，库藏股数量升至1,216,000股。公司已获股东于2025年12月16日通过了回购授权，授权回购股份总数为30,222,358股，目前已累计回购1,216,000股，占该授权通过当日已发行股本的约0.4024%。根据公告，回购后再度进行新股发行或库藏股出售、转让的相关禁售期将持续至2026年6月28日。
公司确认，本次回购事项符合香港联交所证券上市规则及相关法律法规的要求。公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.